Literature DB >> 25876207

Differential effects of inhaled corticosteroids in smokers/ex-smokers and nonsmokers with asthma.

Nicolas Roche1, Dirkje S Postma, Gene Colice, Anne Burden, Theresa W Guilbert, Elliot Israel, Richard J Martin, Willem M C van Aalderen, Jonathan Grigg, Elizabeth V Hillyer, Julie von Ziegenweidt, David B Price.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25876207     DOI： 10.1164/rccm.201411-2116LE

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN： 1073-449X            Impact factor:   21.405


× No keyword cloud information.
  8 in total

1.  2016 Respiratory Effectiveness Group Annual Summit Report-impact & influence of real-world respiratory evidence.

Authors:  Alison Chisholm; Nemr Eid; Bernardino Alcázar-Navarrete; Aji Barot; George Christoff; David B Price
Journal:  J Thorac Dis       Date:  2016-07       Impact factor: 2.895

2.  Effects of Age and Disease Severity on Systemic Corticosteroid Responses in Asthma.

Authors:  Wanda Phipatanakul; David T Mauger; Ronald L Sorkness; Jonathan M Gaffin; Fernando Holguin; Prescott G Woodruff; Ngoc P Ly; Leonard B Bacharier; Nirav R Bhakta; Wendy C Moore; Eugene R Bleecker; Annette T Hastie; Deborah A Meyers; Mario Castro; John V Fahy; Anne M Fitzpatrick; Benjamin M Gaston; Nizar N Jarjour; Bruce D Levy; Stephen P Peters; W Gerald Teague; Merritt Fajt; Sally E Wenzel; Serpil C Erzurum; Elliot Israel
Journal:  Am J Respir Crit Care Med       Date:  2017-06-01       Impact factor: 21.405

3.  Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids.

Authors:  Dirkje S Postma; Richard Dekhuijzen; Thys van der Molen; Richard J Martin; Wim van Aalderen; Nicolas Roche; Theresa W Guilbert; Elliot Israel; Daniela van Eickels; Javaria Mona Khalid; Ron M C Herings; Jetty A Overbeek; Cristiana Miglio; Victoria Thomas; Catherine Hutton; Elizabeth V Hillyer; David B Price
Journal:  Allergy Asthma Immunol Res       Date:  2017-03       Impact factor: 5.764

4.  The effect of DPP-4 inhibitors on asthma control: an administrative database study to evaluate a potential pathophysiological relationship.

Authors:  Gene Colice; David Price; Maria Gerhardsson de Verdier; Karma Rabon-Stith; Christopher Ambrose; Katherine Cappell; Debra E Irwin; Paul Juneau; Anna Vlahiotis
Journal:  Pragmat Obs Res       Date:  2017-12-01

5.  Does co-payment for inhaler devices affect therapy adherence and disease outcomes? A historical, matched cohort study.

Authors:  Jaco Voorham; Bernard Vrijens; Job Fm van Boven; Dermot Ryan; Marc Miravitlles; Lisa M Law; David B Price
Journal:  Pragmat Obs Res       Date:  2017-04-18

6.  Quality standards in respiratory real-life effectiveness research: the REal Life EVidence AssessmeNt Tool (RELEVANT): report from the Respiratory Effectiveness Group-European Academy of Allergy and Clinical Immunology Task Force.

Authors:  Nicolas Roche; Jonathan D Campbell; Jerry A Krishnan; Guy Brusselle; Alison Chisholm; Leif Bjermer; Mike Thomas; Eric van Ganse; Maarten van den Berge; George Christoff; Jennifer Quint; Nikolaos G Papadopoulos; David Price
Journal:  Clin Transl Allergy       Date:  2019-03-27       Impact factor: 5.871

7.  Efficacy of indacaterol/glycopyrronium versus salmeterol/fluticasone in current and ex-smokers: a pooled analysis of IGNITE trials.

Authors:  David M G Halpin; Claus F Vogelmeier; Karen Mezzi; Pritam Gupta; Konstantinos Kostikas; Jadwiga A Wedzicha
Journal:  ERJ Open Res       Date:  2021-02-22

8.  Establishing the relationship of inhaler satisfaction, treatment adherence, and patient outcomes: a prospective, real-world, cross-sectional survey of US adult asthma patients and physicians.

Authors:  David Price; Brooke Harrow; Mark Small; James Pike; Victoria Higgins
Journal:  World Allergy Organ J       Date:  2015-09-10       Impact factor: 4.084
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.